Global Preclinical CRO Market 2023-2027

Description

List of Tables

The preclinical CRO market is forecasted to grow by USD 2253.55 mn during 2022-2027, accelerating at a CAGR of 7.71% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.

Technavio's preclinical CRO market is segmented as below:

By End-user

Pharmaceutical and biopharmaceutical companies
Medical device companies
Academic institutes

By Service

Toxicology testing
Bioanalysis and DMPK studies
Compound management
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical CRO market growth during the next few years. Also, rise in R and D budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical CRO market covers the following areas:

Preclinical CRO market sizing
Preclinical CRO market forecast
Preclinical CRO market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical CRO market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON plc, Imavita S.A.S., IQVIA Inc., JSR Corp., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., Thermo Fisher Scientific Inc., Veeda Clinical Research Ltd., WuXi AppTec Co. Ltd., and Vivotecnia. Also, the preclinical CRO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR75727

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Service
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global preclinical CRO market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global preclinical cro market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Service Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Service Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027
Exhibit 34: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
6.4 Medical device companies - Market size and forecast 2022-2027
Exhibit 38: Chart on Medical device companies - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Medical device companies - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Medical device companies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Medical device companies - Year-over-year growth 2022-2027 (%)
6.5 Academic institutes - Market size and forecast 2022-2027
Exhibit 42: Chart on Academic institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Academic institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Academic institutes - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Academic institutes - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Service

7.1 Market segments
Exhibit 48: Chart on Service - Market share 2022-2027 (%)
Exhibit 49: Data Table on Service - Market share 2022-2027 (%)
7.2 Comparison by Service
Exhibit 50: Chart on Comparison by Service
Exhibit 51: Data Table on Comparison by Service
7.3 Toxicology testing - Market size and forecast 2022-2027
Exhibit 52: Chart on Toxicology testing - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Toxicology testing - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Toxicology testing - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Toxicology testing - Year-over-year growth 2022-2027 (%)
7.4 Bioanalysis and DMPK studies - Market size and forecast 2022-2027
Exhibit 56: Chart on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Bioanalysis and DMPK studies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2022-2027 (%)
7.5 Compound management - Market size and forecast 2022-2027
Exhibit 60: Chart on Compound management - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Compound management - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Compound management - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Compound management - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Service
Exhibit 68: Market opportunity by Service ($ million)
Exhibit 69: Data Table on Market opportunity by Service ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Altasciences
Exhibit 119: Altasciences - Overview
Exhibit 120: Altasciences - Product / Service
Exhibit 121: Altasciences - Key offerings
12.4 AmplifyBio
Exhibit 122: AmplifyBio - Overview
Exhibit 123: AmplifyBio - Product / Service
Exhibit 124: AmplifyBio - Key offerings
12.5 Charles River Laboratories International Inc.
Exhibit 125: Charles River Laboratories International Inc. - Overview
Exhibit 126: Charles River Laboratories International Inc. - Business segments
Exhibit 127: Charles River Laboratories International Inc. - Key news
Exhibit 128: Charles River Laboratories International Inc. - Key offerings
Exhibit 129: Charles River Laboratories International Inc. - Segment focus
12.6 Eurofins Scientific SE
Exhibit 130: Eurofins Scientific SE - Overview
Exhibit 131: Eurofins Scientific SE - Business segments
Exhibit 132: Eurofins Scientific SE - Key news
Exhibit 133: Eurofins Scientific SE - Key offerings
Exhibit 134: Eurofins Scientific SE - Segment focus
12.7 ICON plc
Exhibit 135: ICON plc - Overview
Exhibit 136: ICON plc - Product / Service
Exhibit 137: ICON plc - Key offerings
12.8 Imavita S.A.S.
Exhibit 138: Imavita S.A.S. - Overview
Exhibit 139: Imavita S.A.S. - Product / Service
Exhibit 140: Imavita S.A.S. - Key offerings
12.9 IQVIA Inc.
Exhibit 141: IQVIA Inc. - Overview
Exhibit 142: IQVIA Inc. - Business segments
Exhibit 143: IQVIA Inc. - Key news
Exhibit 144: IQVIA Inc. - Key offerings
Exhibit 145: IQVIA Inc. - Segment focus
12.10 JSR Corp.
Exhibit 146: JSR Corp. - Overview
Exhibit 147: JSR Corp. - Business segments
Exhibit 148: JSR Corp. - Key offerings
Exhibit 149: JSR Corp. - Segment focus
12.11 Kunming Biomed International Ltd.
Exhibit 150: Kunming Biomed International Ltd. - Overview
Exhibit 151: Kunming Biomed International Ltd. - Product / Service
Exhibit 152: Kunming Biomed International Ltd. - Key offerings
12.12 Laboratory Corp. of America Holdings
Exhibit 153: Laboratory Corp. of America Holdings - Overview
Exhibit 154: Laboratory Corp. of America Holdings - Business segments
Exhibit 155: Laboratory Corp. of America Holdings - Key news
Exhibit 156: Laboratory Corp. of America Holdings - Key offerings
Exhibit 157: Laboratory Corp. of America Holdings - Segment focus
12.13 Medpace Holdings Inc.
Exhibit 158: Medpace Holdings Inc. - Overview
Exhibit 159: Medpace Holdings Inc. - Product / Service
Exhibit 160: Medpace Holdings Inc. - Key offerings
12.14 Thermo Fisher Scientific Inc.
Exhibit 161: Thermo Fisher Scientific Inc. - Overview
Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
Exhibit 163: Thermo Fisher Scientific Inc. - Key news
Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus
12.15 Veeda Clinical Research Ltd.
Exhibit 166: Veeda Clinical Research Ltd. - Overview
Exhibit 167: Veeda Clinical Research Ltd. - Product / Service
Exhibit 168: Veeda Clinical Research Ltd. - Key offerings
12.16 Vivotecnia
Exhibit 169: Vivotecnia - Overview
Exhibit 170: Vivotecnia - Product / Service
Exhibit 171: Vivotecnia - Key offerings
12.17 WuXi AppTec Co. Ltd.
Exhibit 172: WuXi AppTec Co. Ltd. - Overview
Exhibit 173: WuXi AppTec Co. Ltd. - Business segments
Exhibit 174: WuXi AppTec Co. Ltd. - Key offerings
Exhibit 175: WuXi AppTec Co. Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 176: Inclusions checklist
Exhibit 177: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 178: Currency conversion rates for US$
13.4 Research methodology
Exhibit 179: Research methodology
Exhibit 180: Validation techniques employed for market sizing
Exhibit 181: Information sources
13.5 List of abbreviations
Exhibit 182: List of abbreviations